Clinical Trial Update: GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update for GLAD-AML using Glasdegib with two decitabine regimens in older patients with poor-risk acute myeloid leukemia; study terminated with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)
• Glasdegib (glasdegib)

Snippet

Sponsor: Yale University | Conditions: ACUTE MYELOID LEUKEMIA | Phase 2 | Status: TERMINATED | Results posted: 2021-10-15